We are live on ! Find out more
XGN icon

Exagen
XGN

29 hedge funds and large institutions have $16.7M invested in Exagen in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

4% more funds holding

Funds holding: 28 → 29 (+1)

0.18% less ownership

Funds ownership: 40.9% → 40.72% (-0.18%)

16% less capital invested

Capital invested by funds: $20M → $16.7M (-$3.29M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$391K
2
Prudential Financial
Prudential Financial
New Jersey
+$26.9K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.7K
4
Millennium Management
Millennium Management
New York
+$3.08K
5
Bank of America
Bank of America
North Carolina
+$2.01K

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$367K
2
NCM
Nantahala Capital Management
Connecticut
-$38.4K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$34.1K
4
BlackRock
BlackRock
New York
-$17.7K
5
BCM
Bridgeway Capital Management
Texas
-$16.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$3.61M – – –
SCM
2
Stonepine Capital Management
Oregon
$2.91M +$391K +154,139 +15%
WA
3
Wasatch Advisors
Utah
$2.1M -$367K -144,571 -14%
CAC
4
Cowen and Company
New York
$2.06M – – –
SAM
5
Silvercrest Asset Management
New York
$1.32M -$5.72K -2,256 -0.4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.19M – – –
Morgan Stanley
7
Morgan Stanley
New York
$1.16M – – –
PCM
8
Perkins Capital Management
Minnesota
$639K – – –
UBS Group
9
UBS Group
Switzerland
$317K – – –
NCM
10
Nantahala Capital Management
Connecticut
$258K -$38.4K -15,125 -12%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$200K +$16.7K +6,583 +9%
PM
12
Penbrook Management
New York
$178K -$1.52K -600 -0.8%
BlackRock
13
BlackRock
New York
$162K -$17.7K -6,964 -9%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$133K -$34.1K -13,462 -20%
BCM
15
Bridgeway Capital Management
Texas
$100K -$16.5K -6,500 -14%
State Street
16
State Street
Massachusetts
$82.5K – – –
Millennium Management
17
Millennium Management
New York
$76.5K +$3.08K +1,216 +4%
Northern Trust
18
Northern Trust
Illinois
$39.8K – – –
FBT
19
First Bank & Trust
South Dakota
$34.8K – – –
Prudential Financial
20
Prudential Financial
New Jersey
$26K +$26.9K +10,600 New
AF
21
Allworth Financial
California
$17K – – –
Bank of America
22
Bank of America
North Carolina
$16.5K +$2.01K +793 +13%
Barclays
23
Barclays
United Kingdom
$12.5K – – –
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$9K +$1.43K +564 +18%
Wells Fargo
25
Wells Fargo
California
$5.93K -$18 -7 -0.3%
1
2

XGN Hedge Fund Activity: Q3 2023 in Review

29 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q3 2023, worth a combined $16.7M — down 16% from $20M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new XGN positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $391K. The largest seller was Wasatch Advisors, cutting an estimated $367K.

  • 29 institutional investors held Exagen (XGN) as of Q3 2023, up from 28 in Q2 2023.
  • Funds reported $16.7M of Exagen stock for Q3 2023, down 16% quarter-over-quarter.
  • 3 funds opened new Exagen positions in Q3 2023 and 1 closed out, a net change of +2 holders.
  • The largest Exagen buyer in Q3 2023 was Stonepine Capital Management, an estimated $391K added.
  • The largest Exagen seller in Q3 2023 was Wasatch Advisors, an estimated $367K sold.

Based on aggregated 13F filings for Q3 2023.